Vivian Chukwurah, MD
Hematology & Oncology · Alexandria, LANPI 1255835138
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,874 of the $3,193 with a category attached, or 90.0%. It is spread thinly across 37 manufacturers, the largest accounting for just 12.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,025 and has fallen 66.1% since, to $348 in 2025. That places this record below the midpoint for hematology & oncology clinicians in LA, where the typical reported total is $4,451.
Across 131 payments — averaging $24.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$411
- Lilly USA, LLC$405
- Pfizer$246
- AstraZeneca$241
- Incyte Corporation$172
- Daiichi Sankyo Inc.$168
- plus $2K from 31 others
What the payments were for
- Food & beverage$2,87490%
- Education$31910%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 24 | $411 |
| Lilly USA, LLC | 10 | $405 |
| Pfizer | 11 | $246 |
| AstraZeneca | 11 | $241 |
| Incyte Corporation | 8 | $172 |
| Daiichi Sankyo Inc. | 7 | $168 |
| Merck | 7 | $135 |
| Bristol Myers Squibb | 4 | $135 |
| Sobi, Inc | 3 | $133 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $132 |
| Abbott | 1 | $118 |
| EMD Serono, Inc. | 1 | $100 |
| Sanofi | 3 | $79 |
| Mirati Therapeutics, Inc. | 3 | $65 |
| Myriad Genetic Laboratories, Inc. | 2 | $59 |
| Seagen Inc. | 3 | $51 |
| Johnson & Johnson | 3 | $51 |
| Astellas Pharma US Inc | 2 | $45 |
| GSK | 2 | $37 |
| Gilead | 2 | $37 |
| Eisai Inc. | 2 | $36 |
| Stemline Therapeutics Inc. | 2 | $30 |
| Tersera Therapeutics LLC | 1 | $28 |
| AbbVie | 1 | $27 |
| Adaptive Biotechnologies Corporation | 1 | $26 |
| Global Blood Therapeutics, Inc. | 1 | $25 |
| Pharmaessentia USA Corporation | 1 | $24 |
| Genentech USA, Inc. | 1 | $23 |
| Genmab U.S., Inc. | 1 | $21 |
| Novocure Inc. | 1 | $19 |
| ADC Therapeutics America, Inc. | 1 | $19 |
| Pharmacosmos Therapeutics Inc. | 1 | $19 |
| Ipsen Biopharmaceuticals, Inc | 1 | $19 |
| Geron Corporation | 1 | $17 |
| Sun Pharmaceutical Industries Inc. | 1 | $16 |
| Beigene USA, Inc. | 1 | $14 |
| Jazz Pharmaceuticals Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AMPLATZER AMULET$118
How this compares
$3,193 in reported general payments places this provider in the 40th percentile of 183 hematology & oncology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other hematology & oncology in Alexandria
- Hafez HalawaniAlexandria$18K
- Bassam Abi-RachedAlexandria$13K
- Hana SafahBaton Rouge$2M
- Pedro BarataNew Orleans$928K
- Maissaa JanbainNew Orleans$862K
- Nakhle SabaBaton Rouge$842K
- Marc MatranaNew Orleans$757K
- Prakash PeddiShreveport$405K
- Sanjay JunejaBaton Rouge$346K
- Lingling duNew Orleans$173K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.